MH1 Fab' fragment of a monoclonal antibody targeted to fibrin in clots and labeled with technetium-99m: Completed a Phase I trial and beginning Phase I/II trial

American Biogenetic Sciences Inc. (MABXA), Copiague, N.Y. Product: MH1 Fab' fragment of a monoclonal antibody targeted to fibrin in clots and labeled with technetium-99m Indication: Pulmonary embolism...